Clinical Trial Update: Pharmaceutical Treatment of Fatigue After Aneurysmal Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a pharmaceutical treatment for fatigue following aneurysmal subarachnoid hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Snippet

Sponsor: Oslo University Hospital | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED